GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Odyssey Group International Inc (OTCPK:ODYY) » Definitions » Cash Ratio

Odyssey Group International (Odyssey Group International) Cash Ratio : 0.03 (As of Jan. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Odyssey Group International Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Odyssey Group International's Cash Ratio for the quarter that ended in Jan. 2024 was 0.03.

Odyssey Group International has a Cash Ratio of 0.03. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.

The historical rank and industry rank for Odyssey Group International's Cash Ratio or its related term are showing as below:

ODYY' s Cash Ratio Range Over the Past 10 Years
Min: 0.01   Med: 0.03   Max: 0.57
Current: 0.03

During the past 9 years, Odyssey Group International's highest Cash Ratio was 0.57. The lowest was 0.01. And the median was 0.03.

ODYY's Cash Ratio is ranked worse than
96.84% of 855 companies
in the Medical Devices & Instruments industry
Industry Median: 1.23 vs ODYY: 0.03

Odyssey Group International Cash Ratio Historical Data

The historical data trend for Odyssey Group International's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Odyssey Group International Cash Ratio Chart

Odyssey Group International Annual Data
Trend Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Cash Ratio
Get a 7-Day Free Trial Premium Member Only 0.15 0.09 0.16 0.01 0.01

Odyssey Group International Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 - 0.01 0.03 0.03

Competitive Comparison of Odyssey Group International's Cash Ratio

For the Medical Devices subindustry, Odyssey Group International's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Odyssey Group International's Cash Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Odyssey Group International's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Odyssey Group International's Cash Ratio falls into.



Odyssey Group International Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Odyssey Group International's Cash Ratio for the fiscal year that ended in Jul. 2023 is calculated as:

Cash Ratio (A: Jul. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=0.037/6.612
=0.01

Odyssey Group International's Cash Ratio for the quarter that ended in Jan. 2024 is calculated as:

Cash Ratio (Q: Jan. 2024 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=0.166/5.379
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Odyssey Group International  (OTCPK:ODYY) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Odyssey Group International Cash Ratio Related Terms

Thank you for viewing the detailed overview of Odyssey Group International's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Odyssey Group International (Odyssey Group International) Business Description

Traded in Other Exchanges
N/A
Address
2300 West Sahara Avenue, Suite 800 - No. 4012, Las Vegas, NV, USA, 89102
Odyssey Group International Inc is a company focused on developing life-saving medical products, Odyssey's goal is to create, acquire and accumulate distinct assets, intellectual property, and technologies that provide meaningful medical solutions. The Company is focused on building and acquiring assets in areas that have an identified technological advantage, provide superior clinical utility, and have a substantial market opportunity.
Executives
Erik C. Emerson other: Chief Commercial Officer 2300 WEST SAHARA AVENUE, SUITE 800 - #4012, LAS VEGAS NV 89102
Gregory W Gironda other: Chief Operating Officer 2300 WEST SAHARA AVENUE, SUITE 800 - #4012, LAS VEGAS NV 89102
Ricky Richardson director 2372 MORSE AVE., IRVINE CA 92614
Christine Farrell officer: Controller/Secretary 2372 MORSE AVE, IRVINE CA 92614
John P Gandolfo director 62 TERRACE ROAD, WAYNE NJ 07470
Jerome H Casey director 2372 MORSE AVE, IRVINE CA 92614
Jeffrey X Conroy director 2372 MORSE AVE, IRVINE CA 92614
Vanlandingham Jacob Ph.d director 2372 MORSE AVE, IRVINE CA 92614
J Michael Redmond director, officer: President/CEO 10 CANTERBURY ROAD, WINDHAM NH 03087

Odyssey Group International (Odyssey Group International) Headlines

From GuruFocus